Courbon Eve, Tanguay Cynthia, Lebel Denis, Bussières Jean-François
est candidate au D. Pharm et assistante de recherche à l'Unité de recherche en pratique pharmaceutique, Centre hospitalier universitaire Sainte-Justine, Montréal, Québec. Elle est aussi interne en pharmacie, Université Paris Sud XI, Paris, France.
, B. Sc., M. Sc, est coordonnatrice à l'Unité de recherche en pratique pharmaceutique, Centre hospitalier universitaire Sainte-Justine, Montréal, Québec.
Can J Hosp Pharm. 2014 May;67(3):188-96.
Honorary and ghost authorship, as well as competing interests, are well documented concerns related to the publication of scientific articles. Guidelines for writing and publishing scientific manuscripts are available, including those of the International Committee of Medical Journal Editors (ICMJE).
The primary objective of this descriptive cross-sectional study was to identify, in the instructions for authors of pharmacy practice journals, guidance on authorship and competing interests. The secondary objective was to suggest suitable corrective measures for more transparent authorship.
The first step of the project was to identify journals in the area of pharmacy practice. The instructions for authors of each journal were then reviewed to determine recommendations for avoiding problems related to authorship and competing interests. Finally, the members of the research team formulated potential corrective measures for researchers.
Of 232 pharmacy journals identified, 33 were deemed to focus on pharmacy practice. A total of 24 (73%) of these journals mentioned that they followed ICMJE policies, 14 (42%) asked authors to complete a competing interests disclosure form at the time of submission, 17 (52%) had a formal definition of authorship, and 5 (15%) asked for details of each author's contribution. A list of 40 criteria was developed to define authorship status.
Fewer than half of the journals asked authors to provide a competing interests disclosure form upon submission of an article, and only half had a formal definition of authorship. The scientific publication of papers relevant to pharmacy practice is not free from issues related to publication transparency. Publishing articles online and using a checklist to detail each author's contribution may help to limit the associated risks. [Publisher's translation].
荣誉作者和挂名作者以及利益冲突是与科学文章发表相关的有充分记录的问题。目前已有关于撰写和发表科学稿件的指南，包括国际医学期刊编辑委员会（ICMJE）的指南。
这项描述性横断面研究的主要目的是在药学实践期刊的作者指南中确定关于作者身份和利益冲突的指导。次要目的是为更透明的作者身份提出合适的纠正措施。
该项目的第一步是确定药学实践领域的期刊。然后对每种期刊的作者指南进行审查，以确定避免与作者身份和利益冲突相关问题的建议。最后，研究团队成员为研究人员制定了潜在的纠正措施。
在确定的232种药学期刊中，33种被认为专注于药学实践。其中共有24种（73%）期刊提到它们遵循ICMJE政策，14种（42%）要求作者在投稿时填写利益冲突披露表，17种（52%）对作者身份有正式定义，5种（15%）要求提供每位作者贡献的详细信息。制定了一份包含40条标准的清单来定义作者身份状态。
不到一半的期刊要求作者在提交文章时提供利益冲突披露表，只有一半对作者身份有正式定义。与药学实践相关的论文的科学发表并非不存在与发表透明度相关的问题。在线发表文章并使用清单详细说明每位作者的贡献可能有助于降低相关风险。[出版商翻译]
